Safety and efficacy of oral HD-03/ES given for six months in patients with chronic hepatitis B virus infection

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 30

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

339

HTML

2148

Figures (1-4)

216

Tables (1-4)

241

Sum=2944

Aug 14, 2007 (publication date) through Nov 8, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Aug 14, 2007; 13(30): 4103-4107
Published online Aug 14, 2007. doi: 10.3748/wjg.v13.i30.4103

Table 3 Biochemical and serological response to 6 mo of HD-03/ES therapy

^aP < 0.05; vs d 0;

^bP < 0.001 vs d 0.

Citation: Rajkumar J, Sekar M, Mitra S. Safety and efficacy of oral HD-03/ES given for six months in patients with chronic hepatitis B virus infection. World J Gastroenterol 2007; 13(30): 4103-4107
URL: https://www.wjgnet.com/1007-9327/full/v13/i30/4103.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i30.4103